Metraipolis › archive › dc_ca9f71e6fa61
Renalase is a novel tissue and serological biomarker in pancreatic ductal adenocarcinoma — Europe PMC PMID:34587190
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/34587190
- DOI
- 10.1371/journal.pone.0250539
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-02T15:16:53.373Z
- SHA-256 of the archived text
e7147982cd6e673007011c8e8c8372be9f6a667321a831f509394ec0660fa168- Stable URL of this page
https://metraipolis.com/documento/dc_ca9f71e6fa61
How to cite
Renalase is a novel tissue and serological biomarker in pancreatic ductal adenocarcinoma — Europe PMC PMID:34587190 — Europe PMC (en), https://europepmc.org/article/MED/34587190 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_ca9f71e6fa61 (Metraipolis archive dc_ca9f71e6fa61, sha256 e7147982cd6e673007011c8e8c8372be9f6a667321a831f509394ec0660fa168)
BibTeX
@misc{dcca9f71e6fa61,
title = {Renalase is a novel tissue and serological biomarker in pancreatic ductal adenocarcinoma — Europe PMC PMID:34587190},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/34587190},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_ca9f71e6fa61; sha256 e7147982cd6e673007011c8e8c8372be9f6a667321a831f509394ec0660fa168},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/34587190. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Dysregulated expression of the secretory protein renalase can promote pancreatic ductal adenocarcinoma (PDAC) growth in animal models. We characterized renalase expression in premalignant and malignant PDAC tissue and investigated whether plasma renalase levels corresponded to clinical PDAC characteristics. Renalase immunohistochemistry was used to determine the presence and distribution of renalase in normal pancreas, chronic pancreatitis, PDAC precursor lesions, and PDAC tissues. Associations between pretreatment plasma renalase and PDAC clinical status were assessed in patients with varied clinical stages of PDAC and included tumor characteristics, surgical resection in locally advanced/borderline resectable PDAC, and overall survival. Data were retrospectively obtained and correlated using non-parametric analysis. Little to no renalase was detected by histochemistry in the normal pancreatic head in the absence of abdominal trauma. In chronic pancreatitis, renalase immunoreactivity localized to peri-acinar spindle-shaped cells in some samples. It was also widely present in PDAC precursor lesions and PDAC tissue. Among 240 patients with PDAC, elevated plasma renalase levels were associated with worse tumor characteristics, including greater angiolymphatic invasion (80.0% vs. 58.1%, p = 0.012) and greater node positive disease (76.5% vs. 56.5%, p = 0.024). Overall survival was worse in patients with high plasma renalase levels with median follow-up of 27.70 months vs. 65.03 months (p < 0.001). Renalase levels also predicted whether patients with locally advanced/borderline resectable PDAC underwent resection (AUC 0.674; 95%CI 0.42-0.82, p = 0.04). Overall tissue renalase was increased in both premalignant and malignant PDAC tissues compared to normal pancreas. Elevated plasma renalase levels were associated with advanced tumor characteristics, decreased overall survival, and reduced resectability in patients with locally advanced/borderline resectable PDAC. These studies show that renalase levels are increased in premalignant pancreatic tissues and that its levels in plasma correspond to the clinical behavior of PDAC. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PloS one, 2021 (prima pubblicazione 2021-09-29). Identificativi: PMID 34587190 · PMCID PMC8480607 · DOI 10.1371/journal.pone.0250539. Descrittori MeSH principali: Up-Regulation. Pagina: https://europepmc.org/article/MED/34587190 — https://doi.org/10.1371/journal.pone.0250539. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-11-02T15:07:34.539Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.